Ticker Symbol: INSM
Insmed Inc
$30.72 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001104506
Company Profile
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United Statesand the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europeand in Japan. .
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 700 US Highway 202/206
Website: www.insmed.com
CEO: William Lewis
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $24.76
Change:
$0.30
(
1.23%)
Days Range: $24.06 - $24.78
Beta: 0.79
52wk. High: $27.59
52wk. Low: $16.04
Ytd. Change 25.15%
50 Day Moving Average: $25.63
200 Day Moving Average: $21.42
Shares Outstanding: 143800000
Valuation
Market Cap: 356.0B
PE Ratio: -4.69
EPS (TTM): -5.28
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A